Background: Osteopontin (OPN) is associated with tumor formation, progression and metastasis, and increased OPN levels have been associated with poor survival in breast cancer. We investigated the mechanisms responsible for OPN activity, and the relationships between OPN expression and clinical parameters in breast cancer. Methods: OPN mRNA and protein levels were compared in malignant and benign breast tumors by polymerase chain reaction (PCR) and immunohistochemistry, respectively, and levels in breast cancer cells were determined by PCR and western blotting. The effects of lentiviral-mediated knockdown of OPN 
Breast cancer is the most common cancer and the second leading cause of cancerrelated mortality in women worldwide [1] . A better understanding of the molecular basis of breast cancer is thus essential to improve the prognosis of this disease. Osteopontin (OPN) is a matricellular protein that binds to cell surface receptors, including integrins and CD44, resulting in a wide range of effects [2] . OPN plays important physiological roles known as a tumor-associated protein, and elevated OPN has been detected in a wide range of human tumors, such as breast [6, 7] , prostate [8, 9] , liver [10], cervical [11] and lung cancers [12, 13] . Overexpression of OPN has also been detected in tumor cells and tumor-
The roles of OPN in cancer are mediated by binding to a range of cell surface receptors, growth factor/receptor pathways, and proteases [16] . OPN has been shown to interact with v 1 v 3 v v 6 8 1 1 [17, 18] , via the Arg-Gly-Asp 9 1 4 1 4 7 [19, 20] via the serine-valine-valine-tyrosineglutamate-leucine-arginine (SVVYGLR) sequence. The interaction of OPN with cell surface receptors can in turn activate various signal transduction pathways, resulting in changes in gene expression and leading to alterations in cell behavior, including migration, invasion and apoptosis [21, 22] . However, although OPN is known to be associated with cell migration and invasion in breast cancer, the precise mechanisms responsible for this role remain unclear.
The phosphoinositide 3-kinase (PI3K)/Akt/mTOR pathway is well known to be involved in the control of migration, invasion and apoptosis in cancer [23, 24] , and PI3K/ also been shown to inhibit autophagy, and thus promote tumorigenesis [26] . However, the coordinated involvement of these factors in breast cancer has not yet been demonstrated.
In this study, we therefore analyzed the relationships between OPN and autophagyrelated-gene expression in clinical benign tumor and breast tumor samples in vivo. We also compared the gene and protein expression levels of OPN in breast cancer cells in vitro, and v 3 , LC3 I/II and Beclin 1 expression. We further examined the effects of OPN knockdown on cell migration, invasion, apoptosis, and the molecular pathways involved in these processes. The results of this study will help to clarify the complex mechanisms whereby OPN may promote breast cancer, and thus identify potential targets for future drug development.
Materials and Methods
Patients and tissue samples A total of 60 invasive ductal carcinoma breast tissue samples and 11 benign breast tumor tissue samples were obtained from patients who underwent surgical treatment at the Center Hospital of Nanyang City from May 2012 to March 2013, after obtaining written consent. All the patients were women, with a tissues were staged according to the American Joint Committee on Cancer (AJCC) breast cancer TNM staging stored in liquid nitrogen for subsequent experiments. OPN expression was analyzed in relation to patient age, clinical stage, tumor size, axillary lymph node status, and expression levels of estrogen receptor (ER), progesterone receptor (PR) and c-erb-B2.
Immunohistochemistry
Histological sections were cut and stained by immunohistochemistry (IHC), as described previously [27] . Antibodies to OPN, ER, PR, and c-erb-B2 were obtained from Abcam (Cambridge, MA, USA). Bound Quantitative real-time polymerase chain reaction analysis RNA extraction, reverse transcription (RT) and quantitative real-time-polymerase chain reaction or tissues using Trizol reagent (Invitrogen) according to the manufacturer's instructions. RT was performed using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems Foster City, CA, USA). QPCR was performed using an ABI prism 7900 sequence detection system and SYBR green Rox Master Mix (Qiagen, o o method and expression was shown relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Western blotting
Total protein of cells or tissues was extracted using RIPA Extraction Reagents (Pierce, Rockford, IL, USA), as described previously [30] . The lysate protein concentration was estimated using a BCA protein assay kit incubated with the primary antibodies overnight at 4 o C. Primary antibodies were purchased from Abcam (1:1000);
washing three times in TBST, membranes were incubated with secondary antibodies (goat anti-rabbit IgG used as a loading control. Blots were developed using the enhanced chemiluminescence procedure and (National Institutes of Health, Bethesda, MD, USA).
RNA interference
Small interfering RNA (siRNA) was transfected into breast cancer cells using lentiviral vectors, prepared designed and synthesized by Ambion (Austin, TX, USA). pLVTHM, pCMV and pMD2G plasmids were purchased from Invitrogen. siRNA sequences were subcloned into the MluI/ClaI sites of the pLVTHM vector. Lentiviral vectors were produced by transient transfection of 293T cells. Titers of lenti-OPN-siRNA vectors 8 transducing units/ml. MDA-MB-231 cells were subsequently infected with control siRNA (con-siRNA) and OPN-siRNA lentiviruses.
Cell migration
The mobility of MDA-MB-231 cells was assessed by scratch wound assays, as described previously 6-well plates at 37 counted under a microscope.
Apoptosis detection
Apoptosis was detected by propidium iodide (PI) and annexin-V staining, as described previously mediated OPN-siRNA or con-siRNA, and grown for 48 h. The cells were then resuspended in binding buffer cytometry was performed using a FACS 440 (BD Biosciences) with a 488 nm argon ion laser. All experiments were performed in triplicate. The lower left quadrant indicated viable cells, the lower right indicated early apoptotic cells, the upper right indicated late apoptotic cells, and the upper left quadrant indicated mechanically-injured cells.
Statistical analysis
Statistical analyses were performed using SPSS 19.0 statistical software packages (SPSS Science, Data for QPCR, western blot, and migration, invasion and apoptosis assays were analyzed using Student's t expression between mock-and con-siRNA-infected cells.
Effect of OPN knockdown on cell invasion and migration
determined by scratch assay. Similarly, cell invasion determined by Transwell migration was
Effect of OPN knockdown on apoptosis
Apoptosis in MDA-MB-231 cells was greatly increased by OPN knockdown, represented cytometry (Fig. 6) .
Effect of OPN knockdown on integrin, autophagy-related genes and PI3K/Akt/mTOR pathway
reduced by OPN knockdown at both mRNA (Fig. 7A ) and protein levels (Fig. 7B) , compared expression between mock-and con-siRNA-infected cells. Protein expression levels of the Cellular Physiology and Biochemistry (Fig 7C) , as demonstrated by western blotting. PI3K, p-Akt and p-mTOR levels were also demonstrated by western blotting, siRNA-infected MDA-MB-231 cells, compared with mock-and consiRNA-infected cells (Fig. 7D ).
Discussion
We demonstrated that OPN expression was increased in breast cancer, both in vivo and in tometric analysis with annexin-V/PI douvitro. OPN was positively associated with increasing stage and lymph node metastasis in clinical samples (Fig. 1) , and with increasing aggressiveness in cancer cell lines (Fig. 3) . The autophagy-related genes LC3 and Beclin 1 were also down-regulated in breast cancer tissues (Fig. 2) . In terms of its cellular effects, OPN increased cell migration and invasion, (Fig. 7) , which mediates cell migration and invasion, and increased expression of LC3 and Beclin 1, thus providing a mechanistic explanation for the role of OPN in breast cancer. Despite progress in the understanding of breast cancer and the development of new therapies, breast cancer remains the second leading cause of cancer-related deaths in factors associated with breast cancer metastasis may therefore help in the development of more effective treatments.
OPN has been shown to be strongly associated with tumor progression [7, 9, 11, 36] and has been shown to cause metastasis in a rat breast cancer model [37] . In addition, high circulating levels of OPN have been reported in patients with metastatic breast cancer [27] .
aggressiveness of breast cancer cell lines. In addition, OPN expression was positively and to correlate with metastasis and poor prognosis [27, 38] . OPN expression also increased with increasing cancer stage, and was higher in breast cancer patients with lymph node metastasis.
Cell migration and invasion are essential characteristics of tumor metastasis. The results of this study showed that OPN knockdown reduced the migration and invasion of aggressive breast cancer cells, in accordance with previous studies that demonstrated a relationship between OPN expression and increased cell migration and adhesion [39] [40] [41] . OPN mediates integrin, but also by regulating its expression levels. PI3K regulates the cell cycle via phosphorylation of Akt and mTOR. This signaling pathway thus plays an important role in apoptosis and cancer, and has been shown to be -mediated migration of prostate cancer cells required activation of this pathway. Akt activation has also been shown to be by reducing intercellular adhesion [46] .
Autophagy is an important process that protects against tumorigenesis. Beclin 1 is essential for autophagy, but is phosphorylated and inactivated by Akt [26] . Given that the PI3K/Akt/mTOR pathway was inhibited by OPN knockdown in the current study, this further supports the importance of autophagy, as well as cancer cell migration and invasion, in OPNmediated breast cancer and metastasis. , thus activating the PI3K/Akt/mTOR pathway. These results further our understanding of the complex mechanisms responsible for breast cancer metastasis, and highlight the existence of several potential new targets for the treatment of patients with metastatic breast cancer.
